• SENSEX 74,781.76
    -120.83 (--0.16%)
  • BANKNIFTY 56,606.55
    134.60 (+0.24%)
  • Molbio Diagnosti
    1,393.10 925.80(%)
  • Pine Labs
    206.10 283.70(%)
  • Larsen & Toubro
    3,880.55 3,288.65(%)
  • HDFC Bank
    708.90 1,020.35(%)
  • Power Grid Corpn
    268.30 250.05(%)
  • ESDS Software
    1,716.35 1,716.35(%)
  • Trent
    2,815.00 3,497.35(%)
  • Raymond
    1,024.00 1,024.00(%)
  • Metro Brands
    924.20 883.40(%)
  • Reliance Industries
    1,253.20 1,250.55(%)
  • Billionbrains
    200.90 227.00(%)
  • Ather Energy
    1,615.00 530.65(%)
  • One 97
    1,829.50 1,829.50(%)
  • Hind.Aeronautics
    4,861.65 3,479.20(%)
  • UPL
    567.25 558.00(%)
  • HDFC Life Insur.
    531.15 796.60(%)
  • Bajaj Finance
    1,015.40 788.40(%)
  • Lodha Developers
    1,076.00 650.85(%)
  • Dhoot Transmission
    1,727.35 1,727.35(%)
  • Britannia Inds.
    4,946.05 4,946.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Albert David Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 1254.0
  • ISIN : INE155C01010
844.35 -6 (-0.66%)
  • As on 12 Sep 2026 (EOD)

  • Today’s Low

    835.50

  • Today’s High

    850.45

  • Open

    847.65

  • Perv Close

    850.00

  • 52W Low

    579.90

  • 52W High

    931.85

Key Indicators

  • P/E(TTM)

    21.41

  • Mar.Cap (₹Cr.)

    482.12

  • Div & Yield %

    0.59

  • Book Value(₹)

    685.71

  • Debt-Equity Ratio

    -0.66

  • AGM Date

    11-Sep-2026

  • EPS

    39.52

  • P/E Ratio

    21.41

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    482.12

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.71

  • BV (₹)

    685.70

  • Sales( ₹ in Cr.)

    333.60

  • NP (in Cr.)

    -1.73

  • NP Var(%)

    -110.0

  • Div%

    50.0

  • CPS (₹)

    14.10

  • EPS (₹)

    -3.00

  • Traded Value (₹ in Lakhs)

    483.15

  • 52 Week High

    931.85

  • 52 Week Low

    579.90

  • Price BSE

    846.0

  • Price NSE

    844.00

  • Market Capital( in Cr.)

    483.15

  • P/C Ratio

    60.10

  • P/E Ratio

    -279.90

  • Price Vs.BV

    -3.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 333.60 345.77 362.46 341.56 313.51 247.45
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 333.60 345.77 362.46 341.56 313.51 247.45
Other Income 7.45 29.58 57.55 15.40 15.84 17.18
Stock Adjustments -4.96 14.33 1.77 4.60 -2.38 -3.30
Total Income 336.09 389.68 421.78 361.56 326.97 261.33
EXPENDITURE :            
Raw Materials 108.90 130.61 128.17 128.67 112.56 82.87
Power and Fuel Cost 15.52 15.17 16.42 18.85 13.22 8.52
Employee Cost 102.48 109.02 88.43 81.07 85.38 82.70
Other Manufacturing Expenses 8.70 9.45 8.04 7.17 7.14 6.68
Selling and Administration Expenses 64.10 73.86 63.45 55.69 44.15 37.09
Miscellaneous Expenses 23.21 18.82 12.74 10.25 7.75 7.01
Employee Benefit Expenses 102.48 109.02 88.43 81.07 85.38 82.70
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 322.90 356.93 317.24 301.69 270.20 224.87
Operating Profit 13.19 32.75 104.54 59.86 56.77 36.46
Interest 2.90 0.55 0.43 0.58 0.67 0.78
Gross Profit 10.29 32.20 104.11 59.28 56.10 35.68
Depreciation 9.76 6.97 6.83 8.55 8.81 8.23
Profit Before Tax 0.53 25.23 97.28 50.73 47.29 27.45
Current Tax 3.29 5.92 17.59 15.96 12.61 4.37
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -1.28 2.10 4.28 -1.40 -0.57 0.93
Reported Net Profit -1.49 17.20 75.42 36.17 35.26 22.14
Extraordinary Items 0.23 0.35 0.00 0.01 1.72 0.75
Adjusted Net Profit -1.72 16.85 75.42 36.16 33.54 21.39
Adjustment below Net Profit 3.22 -0.31 2.96 0.65 0.55 -0.25
P & L Balance brought forward 249.09 238.77 165.53 133.84 101.46 79.57
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 2.85 6.56 5.14 5.14 3.42 0.00
P & L Balance carried down 247.96 249.09 238.77 165.53 133.84 101.46
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 50.00 50.00 115.00 90.00 90.00 60.00
Dividend Per Share(Rs) 5.00 5.00 11.50 9.00 9.00 6.00
Earnings Per Share-Unit Curr -2.62 30.14 132.15 63.38 61.78 38.80
Earnings Per Share(Adj)-Unit Curr -2.62 30.14 132.15 63.38 61.78 38.80
Book Value 686.04 687.70 671.05 545.93 489.68 428.20
Book Value(Adj)-Unit Curr 686.04 687.70 671.05 545.93 489.68 428.20

Shareholding Pattern

  • Promoter Group

    62.24%

  • Public Share Holding

    37.76%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,854,431 50.01 2,854,431 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 697,527 12.22 697,527 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,551,958 62.24 3,551,958 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 700 0.01 0 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 32,267 0.57 32,267 4
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 91,850 1.61 91,850 1
Mutual Funds / UTI 800 0.01 0 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 125,617 2.20 124,117 8
2] Non Institution
Bodies Corporate 0 0.00 0 0
Clearing Members 71,264 1.25 71,264 14
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 164,232 2.88 163,907 360
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 107,357 1.88 107,355 437
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 156,257 2.74 156,257 5
Individuals holding nominal share capital up to Rs. 1 lakh 1,444,597 25.31 1,410,119 12,315
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 45,679 0.80 45,679 1
Sub Total 2,029,587 35.56 1,994,782 13,139
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 5,707,162 100.00 5,670,857 13,155

Company Background

Albert David LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Albert David Ltd
  • BSE Code : 1254.0
  • ISIN : INE155C01010

  • Incorporation Year

    1938

  • Registered Office

    D Block 3rd Flr Gillander Hous
    Netaji Subhas Road, Kolkata,
    West Bengal-700001

  • Telephone

    91-33-22302330/2262 8436/8456/

  • FAX

    91-33-22628439

  • Chairman

    A K Kothari

  • Managing Director

  • Company Secretary

    LALIT LOHIA

  • Auditor

    L B Jha & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Maheshwari Datamatics Pvt Ltd
    23 RN Mukherjee Road,
    5th Floor ,
    Mumbai - Kolkata-700001

Albert David Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Albert David 846.15 341.05 333.60 21.41 0.82
Abbott India 25,586.10 7,217.19 6,929.05 33.67 43.78
Astrazeneca Phar 6,785.35 2,304.07 2,275.58 100.01 27.86
Glaxosmi. Pharma 2,837.20 3,932.76 3,790.20 45.32 58.17
Novartis India 2,393.15 393.10 354.33 60.43 15.94
Cipla 1,365.00 20,102.60 18,979.95 35.87 13.88
Bliss GVS Pharma 722.45 773.53 729.81 67.14 12.51
Amrutanjan Healt 490.35 520.13 502.55 26.26 24.16
Fermenta Biotec. 475.05 474.15 450.25 22.18 18.77
Guj. Themis Bio. 423.35 168.25 165.82 113.20 18.05
Ambalal Sarabhai 40.61 19.52 3.94 75.20 6.77